Skip to content
Monday, November 9, 2026
Stay updated with the newest video game releases, in-depth …

Zimbabwe Turns Down ‘One-Sided’ US Health Aid Package Over Data Concerns

Health aid illustration
The offered American funding was aimed at programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has rejected a substantial US healthcare agreement valued at $367m (272 million pounds) spanning five years over the United States' demand for sensitive biological samples.

The decision came to light following a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "skewed".

An official representative later explained that the United States was demanding access to health data for scientific study and profit while refused to guarantee the benefits from future medical innovations.

"We will now turn to the difficult and regrettable process of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the United States had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.

A medical body in Zimbabwe has urged continued negotiations to find a agreement suitable to all parties so the country's vital HIV programme can be sustained.

Broader Context

This development follows a similar situation in Kenya, where a court blocked a similar health funding agreement after concerns were raised about the safety of citizens' health data.

After resuming office recently, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).

USAID had overseen aid for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing direct bilateral deals to boost openness and accountability.

According to statements, 16 nations in Africa have so far agreed to similar health pacts, constituting more than $18.3bn in committed funds.

Details of the Declined Agreement

This assistance for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on HIV treatment through American-funded programmes," Tremont said.

However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to share its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.

"In essence, our country would supply the basic resources for scientific discovery without any certainty that the end products would be accessible to our population should a new disease outbreak arise."

National Interest and Global Health

Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining frameworks previously set up via the international health agency.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.

"This framework is intended to guarantee that when a nation contributes its data, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the funds to create them."

These objections regarding the US deal "are not meant as anti-American sentiment," he added.

"We are open to further dialogue with our US partners on how subsequent co-operation might be structured in a manner that respects the sovereignty and dignity of both nations."

Medical Community Response

A leading public health body said it recognised the official position, but suggested that negotiations should continue considering much of the country's HIV programmes were funded by external financing.

"Where specific concerns arise, including those involving information security or agreement terms, these can often be resolved through technical clarification and mutually agreed protections," the group said.

This impasse underscores the ongoing debate between accepting vital foreign assistance and safeguarding local interests in an increasingly data-driven world.

DW
About the author

Donna Warren

A passionate gaming journalist with over a decade of experience covering console and PC titles, specializing in indie game analysis and industry trends.

FreshGames UK

Type to search articles.